mouse gp100 plasmid DNA vaccine

BIOLOGICAL2 trials

Sponsors

Memorial Sloan Kettering Cancer Center

Conditions

Intraocular MelanomaMelanoma (Skin)

Phase 1

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

CompletedNCT00104845

Memorial Sloan Kettering Cancer CenterMelanoma (Skin)

Start: 2004-09-30End: 2011-09-30Updated: 2013-03-12

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

CompletedNCT00398073

Memorial Sloan Kettering Cancer CenterIntraocular Melanoma, Melanoma (Skin)

Start: 2006-10-31End: 2011-03-31Updated: 2017-03-16